USA300 methicillin-resistant Staphylococcus aureus in Norway
Article first published online: 23 APR 2013
© 2013 APMIS Published by John Wiley & Sons Ltd
Volume 121, Issue 11, pages 1091–1096, November 2013
How to Cite
USA300 methicillin-resistant Staphylococcus aureus in Norway. APMIS 2013; 121: 1091–1096., , .
- Issue published online: 24 OCT 2013
- Article first published online: 23 APR 2013
- Manuscript Accepted: 9 JAN 2013
- Manuscript Received: 10 NOV 2012
- South-Eastern Norway Regional Health Authority. Grant Number: 2005162
- Time trend analysis;
- molecular epidemiology;
- antibiotic resistance
Moen AEF*, Tannæs TM, Leegaard TM. USA300 methicillin-resistant Staphylococcus aureus (MRSA) in Norway.
Community-associated methicillin-resistant S. aureus USA300 is known for its ability to disseminate and colonize and the clone has been detected globally. We studied the most populated area in Norway in search for the strain and for signs of endemic establishment. Strain typing techniques such as spa-, SCCmec- and dru-typing, pulsed-field gel electrophoresis and detection of USA300 molecular markers, lukS/F-PV and arcA, were performed. USA300 has been present in the study area since 2003 and has increased in incidence in parallel with the total MRSA incidence. Most USA300 isolates were found in the community, but isolates were also detected in health care institutions.